This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Peroxisome proliferator-activated receptor 3D structures

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:11, 23 August 2023) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 4: Line 4:
{{#tree:id=OrganizedByTopic|openlevels=0|
{{#tree:id=OrganizedByTopic|openlevels=0|
-
*'''PPARα'''
+
*'''PPARα''';Ligand-binding domain 201-468
-
**[[1k7l]] – hPPARα LBD + G2409544 + NCOA1 - human<br />
+
**[[1k7l]] – hPPARα + G2409544 + NCOA1 - human<br />
-
**[[3e94]] – hPPARα LBD + fatty acid activator <br />
+
**[[3e94]] – hPPARα + fatty acid activator <br />
-
**[[4bcr]], [[5hyk]] - hPPARα LBD + ligand<br />
+
**[[4bcr]], [[5hyk]] - hPPARα + ligand<br />
-
**[[1kkq]] – hPPARα LBD + GW6471 Antagonist + SMRT<br />
+
**[[1kkq]] – hPPARα + GW6471 Antagonist + SMRT<br />
-
**[[2npa]] - hPPARα LBD+ propanoic acid derivative + NCOA1<br />
+
**[[2p54]] - hPPARα + NCOA1<br />
-
**[[2p54]] - hPPARα LBD + NCOA1<br />
+
**[[5azt]] - hPPARα (mutant) + NCOA1 peptide<br />
-
**[[2rew]] - hPPARα LBD + azetidinone derivative activator<br />
+
**[[2rew]] - hPPARα + azetidinone derivative activator<br />
-
**[[2znn]], [[2zno]], [[2znp]], [[2znq]], [[3kdu]], [[3vi8]], [[1i7g]], [[4bcr]], [[5hyk]] - hPPARα LBD+ agonist<br />
+
**[[2znn]], [[2zno]], [[2znp]], [[2znq]], [[3kdu]], [[3vi8]], [[1i7g]], [[4bcr]], [[5hyk]] - hPPARα + agonist<br />
-
**[[3fei]], [[3fej]], [[3g8i]], [[3sp6]] - hPPARα LBD+ agonist + NCOA1<br />
+
**[[3fei]], [[3fej]], [[3g8i]], [[3sp6]], [[6l96]] - hPPARα + agonist + NCOA1 peptide<br />
-
**[[3et1]] - hPPARα LBD + NCOA1 + indole derivative
+
**[[3sp6]] - hPPARα + hPPARγ peptide + agonist<br />
 +
**[[6kxx]], [[6kxy]] - hPPARα + peptide + agonist<br />
 +
**[[7c6q]] - hPPARα + peptide + sanguinarine<br />
 +
**[[3et1]] - hPPARα + NCOA1 + indole derivative<br />
 +
**[[6kb7]], [[6kba]] - hPPARα + pyrimidine derivative<br />
 +
**[[7e5f]], [[7e5g]], [[7e5h]], [[7e5i]] - hPPARα + propanoic acid derivative<br />
 +
**[[2npa]] - hPPARα + propanoic acid derivative + NCOA1
 +
**[[6jey]], [[6kax]], [[6kay]], [[6kaz]] ,[[6kb0]], [[6kb1]], [[6kb2]], [[6kb3]], [[6kb4]] ,[[6kb5]], [[6kb6]] ,[[6kb8]], [[6kb9]], [[6lx4]], [[6lx5]], [[6lx6]], [[6lx7]], [[6lx8]], [[6lx9]], [[6lxa]], [[6lxb]], [[6lxc]] - hPPARα + ampiphatic carboxylic acid derivative<br />
 +
**[[7bpy]], [[7bpz]], [[7bq0]], [[7bq1]], [[7bq2]], [[7bq3]], [[7bq4]] - hPPARα + NCOA1 + ampiphatic carboxylic acid derivative<br />
 +
**[[6l38]] - hPPARα + benzamide derivative<br />
 +
**[[8hun]], [[8huo]] - hPPARα + anti-NASH drug<br />
 +
**[[6kyp]], [[6l36]], [[6l37]] - hPPARα + benzamide derivative + propanoic acid derivative <br />
 +
**[[8huq]], [[8huk]], [[8hum]] - hPPARα + NCOA1 peptide + anti-NASH drug<br />
-
*'''PPARγ'''
+
**[[5azt]] - hPPARα (mutant) + NCOA1 peptide<br />
-
**[[3prg]], [[2qmv]], [[1prg]] – hPPARγ LBD<br />
+
*'''PPARγ''';Ligand-binding domain 202-475
-
**[[6fzy]], [[6fzg]] - hPPARγ LBD (mutant) <br />
+
-
**[[2zk0]], [[2zk1]], [[2zk2]], [[2zk3]], [[2zk4]], [[2zk5]], [[2zk6]], [[3vjh]], [[3vji]], [[4e4k]], [[4e4q]], [[4jl4]], [[5hzc]], [[4ci5]], [[4ci4]], [[6an1]], [[2f4b]], [[1zeo]], [[2ath]], [[2hwq]], [[2hwr]], [[2i4j]], [[2q59]], [[2q8s]], [[3b3k]], [[3bc5]], [[3cds]], [[3g9e]], [[3gbk]], [[3gz9]], [[3ia6]], [[3kdt]], [[3an3]], [[3an4]], [[3noa]], [[3r5n]], [[3r8a]], [[3vso]], [[3vsp]], [[2xkw]], [[3b0q]], [[3ho0]], [[3hod]], [[1knu]], [[1i7i]], [[1nyx]], [[2pob]], [[5azv]], [[6f2l]], [[6c5t]], [[6c5q]], [[5wr1]], [[5wr0]], [[5wqx]], [[6md2]], [[6md4]], [[6md1]], [[6md0]], [[6mcz]], [[6k0t]], [[6avi]], [[6aug]] – hPPARγ LBD + ligand <br />
+
-
**[[4l98]], [[4l96]] - hPPARγ LBD (mutant) + ligand<br />
+
-
**[[3r8i]] - hPPARγ LBD + ureidofibrate derivative<br />
+
-
**[[6o67]], [[6o68]], [[6dgr]], [[6dgq]], [[6dgo]], [[6dgl]], [[6d8x]], [[6c1i]] - hPPARγ LBD + agonist<br />
+
-
**[[2g0h]], [[2g0g]], [[2i4p]], [[2i4z]], [[2q5g]], [[2q5p]], [[2q5s]], [[2q61]], [[2q6r]], [[3cdp]], [[3d6d]], [[4em9]], [[4ema]], [[4prg]], [[2q6s]], [[5f9b]], [[4yt1]], [[3wmh]], [[6d3e]] - hPPARγ LBD+ partial agonist<br />
+
-
**[[2om9]] - hPPARγ LBD + cannabinoid<br />
+
-
**[[3b0r]], [[5lsg]], [[4r6s]], [[4r2u]], [[4r06]], [[6dh9]], [[6dcu]], [[6dbh]] - hPPARγ LBD + antagonist<br />
+
-
**[[3osi]], [[3osw]], [[3pba]] - hPPARγ LBD + bisphenol derivative<br />
+
-
**[[2p4y]], [[3adt]], [[3adu]], [[3adw]], [[3et3]], [[2hfp]], [[3ty0]] - hPPARγ LBD + modulator<br />
+
-
**[[2zvt]] - hPPARγ LBD (mutant) + modulator<br />
+
-
**[[2vsr]], [[2vst]], [[2vv0]], [[2vv1]], [[2vv2]], [[2vv3]], [[2vv4]], [[3x1i]], [[3x1h]], [[3wj5]], [[3wj4]], [[3po9]], [[3sz1]] - hPPARγ LBD + fatty acid activator<br />
+
-
**[[3ads]], [[3adx]], [[5u5l]], [[4xum]], [[4xuh]], [[4xta]], [[4xld]], [[6d5a]] - hPPARγ LBD + anti-inflammatory drug<br />
+
-
**[[4oj4]] - hPPARγ LBD (mutant) + anti-inflammatory drug<br />
+
-
**[[3adv]] - hPPARγ LBD + serotonin<br />
+
-
**[[3k8s]], [[3et0]], [[2yfe]], [[4a4v]], [[4a4w]], [[4jaz]], [[5tto]], [[4pwl]], [[4pvu]], [[5y2t]], [[5y2o]], [[5ugm]], [[6dha]] - hPPARγ LBD + antidiabetic drug<br />
+
-
**[[4o8f]] - hPPARγ LBD (mutant) + antidiabetic drug<br />
+
-
**[[6enq]] - hPPARγ LBD + antifibrotic drug<br />
+
-
*PPARγ complex with polypeptide
+
**[[3prg]], [[2qmv]], [[1prg]], [[6l8b]], [[6vzo]], [[8cpj]] – hPPARγ<br />
 +
**[[6fzy]], [[6fzg]], [[6t1s]], [[6vzn]], [[7cxe]], [[7e2o]] - hPPARγ (mutant) <br />
 +
**[[2zk0]], [[2zk1]], [[2zk2]], [[2zk3]], [[2zk4]], [[2zk5]], [[2zk6]], [[3vjh]], [[3vji]], [[4e4k]], [[4e4q]], [[4jl4]], [[5hzc]], [[4ci5]], [[4ci4]], [[6an1]], [[2f4b]], [[1zeo]], [[2ath]], [[2hwq]], [[2hwr]], [[2i4j]], [[2q59]], [[2q8s]], [[3b3k]], [[3bc5]], [[3cds]], [[3g9e]], [[3gbk]], [[3gz9]], [[3ia6]], [[3kdt]], [[3an3]], [[3an4]], [[3noa]], [[3r5n]], [[3r8a]], [[3vso]], [[3vsp]], [[2xkw]], [[3b0q]], [[3ho0]], [[3hod]], [[1knu]], [[1i7i]], [[1nyx]], [[2pob]], [[5azv]], [[6f2l]], [[6c5t]], [[6c5q]], [[5wr1]], [[5wr0]], [[5wqx]], [[6md2]], [[6md4]], [[6md1]], [[6md0]], [[6mcz]], [[6k0t]], [[6avi]], [[6aug]], [[6qj5]], [[6t9c]], [[6tdc]], [[6vzl]], [[7lot]], [[7jqg]], [[7wox]] – hPPARγ + ligand <br />
 +
**[[4l98]], [[4l96]] - hPPARγ (mutant) + ligand<br />
 +
**[[3r8i]] - hPPARγ + ureidofibrate derivative<br />
 +
**[[6o67]], [[6o68]], [[6dgr]], [[6dgq]], [[6dgo]], [[6dgl]], [[6d8x]], [[6c1i]] - hPPARγ + agonist<br />
 +
**[[2g0h]], [[2g0g]], [[2i4p]], [[2i4z]], [[2q5g]], [[2q5p]], [[2q5s]], [[2q61]], [[2q6r]], [[3cdp]], [[3d6d]], [[4em9]], [[4ema]], [[4prg]], [[2q6s]], [[5f9b]], [[4yt1]], [[3wmh]], [[6d3e]], [[6l89]], [[7p4e]], [[8dsz]] - hPPARγ + partial agonist<br />
 +
**[[7sqb]], [[8dsy]] hPPARγ + inverse agonist<br />
 +
**[[2om9]] - hPPARγ + cannabinoid<br />
 +
**[[3b0r]], [[5lsg]], [[4r6s]], [[4r2u]], [[4r06]], [[6dh9]], [[6dcu]], [[6dbh]] - hPPARγ + antagonist<br />
 +
**[[3osi]], [[3osw]], [[3pba]] - hPPARγ + bisphenol derivative<br />
 +
**[[2p4y]], [[3adt]], [[3adu]], [[3adw]], [[3et3]], [[2hfp]], [[3ty0]], [[5two]], [[6fzj]], [[6t6b]], [[6y3u]], [[7a7h]], [[8aty]], [[8atz]], [[8cph]], [[8cpi]] - hPPARγ + modulator<br />
 +
**[[2zvt]] - hPPARγ (mutant) + modulator<br />
 +
**[[2vsr]], [[2vst]], [[2vv0]], [[2vv1]], [[2vv2]], [[2vv3]], [[2vv4]], [[3x1i]], [[3x1h]], [[3wj5]], [[3wj4]], [[3po9]], [[3sz1]], [[8bf2]], [[8bff]] - hPPARγ + fatty acid activator<br />
 +
**[[6jey]] - hPPARγ + fatty acid<br />
 +
**[[6jf0]], [[7efq]] - hPPARγ + fluorescent probe<br />
 +
**[[6mcz]], [[6md0]], [[6md1]], [[6md2]], [[6qj5]], [[6t9c]] - hPPARγ + ligand<br />
 +
**[[6tsg]] - hPPARγ + hormone<br />
 +
**[[3ads]], [[3adx]], [[5u5l]], [[4xum]], [[4xuh]], [[4xta]], [[4xld]], [[6d5a]], [[6o67]], [[6o68]], [[7ahj]], [[7awc]], [[7awd]], [[7e0a]] - hPPARγ + anti-inflammatory drug<br />
 +
**[[4oj4]] - hPPARγ (mutant) + anti-inflammatory drug<br />
 +
**[[3adv]] - hPPARγ + serotonin<br />
 +
**[[3k8s]], [[3et0]], [[2yfe]], [[4a4v]], [[4a4w]], [[4jaz]], [[5tto]], [[4pwl]], [[4pvu]], [[5y2t]], [[5y2o]], [[5ugm]], [[6dha]] - hPPARγ + antidiabetic drug<br />
 +
**[[4o8f]], [[6vzm]] - hPPARγ (mutant) + antidiabetic drug<br />
 +
**[[6md4]] - hPPARγ + oleic acid + antidiabetic drug<br />
 +
**[[6enq]] - hPPARγ + antifibrotic drug<br />
 +
**[[6zly]] - hPPARγ + valine derivative <br />
-
**[[1wm0]] – hPPARγ LBD+ NCAO2 peptide + agonist<br />
+
**[[7qb1]], [[8adf]], [[8c0c]], [[8dkv]] - hPPARγ + inhibitor<br />
-
**[[5dwl]], [[5dvc]], [[5dv8]], [[5dv6]], [[5dv3]], [[5dsh]] - hPPARγ LBD+ NCOA2 peptide + inhibitor<br />
+
**[[8hup]] - hPPARg + NCOA1 peptide + anti-NASH drug<br />
-
**[[1zgy]] – hPPARγ LBD+ antidiabetic drug + nuclear receptor peptide<br />
+
-
**[[2gtk]], [[3qt0]], [[5gtp]], [[5gto]], [[5gtn]], [[6jq7]], [[6izm]], [[6ilq]], [[6ijs]], [[6ijr]], [[6icj]], [[5ycp]], [[5ycn]] - hPPARγ LBD+ NCOA1 peptide<br />
+
-
**[[3cs8]], [[3u9q]]- hPPARγ LBD + PGC-1A peptide<br />
+
-
**[[3cwd]] - hPPARγ LBD + NCOA1-2 peptide<br />
+
-
**[[5two]], [[6izn]], [[6fzp]], [[6fzj]], [[6fzf]] - hPPARγ LBD + modulating ligand<br />
+
-
**[[3fur]], [[3kmg]], [[3v9t]], [[3v9v]], [[3v9y]], [[4f9m]], [[3b1m]], [[3lmp]] - hPPARγ LBD + SRC-1 peptide + modulator<br />
+
-
**[[4fgy]], [[2prg]] - hPPARγ LBD + antidiabetic agent + NCOA1 peptide<br />
+
-
**[[6ad9]] - hPPARγ LBD + anticancer agent + NCOA1 peptide<br />
+
-
**[[3s9s]], [[3t03]], [[2fvj]]- hPPARγ LBD + NCOA1 peptide + partial agonist<br />
+
-
**[[4y29]], [[2fvj]], [[5azt]] - hPPARγ LBD + NCOA1 peptide + ligand<br />
+
-
**[[3h0a]] - hPPARγ LBD + SRC 1 + retinoic acid receptor α + retinoic acid + partial agonist<br />
+
-
**[[1k74]], [[1rdt]], [[1fm9]] - hPPARγ LBD + NCOA1 + retinoic acid receptor α + retinoic acid + agonist<br />
+
-
**[[5ji0]] - hPPARγ LBD + retinoic acid receptor + NCOA1 peptide + antidiabetic drug <br />
+
-
**[[3dzu]], [[3e00]], [[3dzy]] - hPPARγ LBD + DNA + retinoic acid receptor α + NCOA2 peptide + retinoic acid<br />
+
-
**[[1fm6]] - hPPARγ LBD + antidiabetic drug + retinoic acid receptor α + NCOA2 peptide + retinoic acid<br />
+
-
**[[3vn2]], [[4hee]], [[4prg]] - hPPARγ LBD + NCOA1 peptide + activator<br />
+
-
**[[6ms7]] - hPPARγ LBD + PGC1 LXXLL<br />
+
-
**[[6dgp]], [[5z6s]], [[5z5s]] - hPPARγ LBD + coactivator peptide<br />
+
-
**[[6d94]] - hPPARγ LBD + mediator of RNA polymerase II peptide<br />
+
-
*'''PPARδ'''
+
*PPARγ complex with NCAO1
-
**[[2gwx]] – hPPARδ LBD<br />
+
**[[2gtk]], [[3qt0]], [[5gtp]], [[5gto]], [[5gtn]], [[5ycp]], [[5ycn]], [[5z6s]], [[5z5s]], [[6dgp]], [[6ilq]], [[6ijs]], [[6ijr]], [[6icj]], [[6jq7]], [[6ktm]], [[7cxf]] - hPPARγ + NCOA1 peptide<br />
-
**[[2env]] – hPPARδ zinc finger domain<br />
+
**[[6t1v]], [[7cxg]], [[7cxh]], [[7cxi]], [[7cxj]], [[7cxk]], [[7cxl]] - hPPARγ (mutant) + NCOA1 peptide<br />
 +
**[[6ktn]] - hPPARγ (mutant) + NCOA1 peptide + leukemia drug<br />
 +
**[[3fur]], [[3kmg]], [[3v9t]], [[3v9v]], [[3v9y]], [[4f9m]], [[3b1m]], [[3lmp]], [[6fzp]], [[8dk4]] - hPPARγ + NCOA1+ modulator<br />
 +
**[[6fzf]] - hPPARγ (mutant) + NCOA1+ modulator<br />
 +
**[[4fgy]], [[2prg]] - hPPARγ + antidiabetic drug + NCOA1 peptide<br />
 +
**[[7wgo]], [[7wgq]] - hPPARγ + hyperlipidaemia drug + NCOA1 peptide<br />
 +
**[[7wgp]] - hPPARγ + pancreatitis drug + NCOA1 peptide<br />
 +
**[[6ad9]] - hPPARγ + anticancer agent + NCOA1 peptide<br />
 +
**[[6izm]], [[6izn]], [[8dkn]] - hPPARγ + pyridine derivative + NCOA1 peptide<br />
 +
**[[3s9s]], [[3t03]], [[2fvj]]- hPPARγ + NCOA1 peptide + partial agonist<br />
 +
**[[4y29]], [[2fvj]], [[5azt]] - hPPARγ + NCOA1 peptide + ligand<br />
 +
**[[3h0a]] - hPPARγ + NCOA1 + retinoic acid receptor + retinoic acid + partial agonist<br />
 +
**[[1k74]], [[1rdt]], [[1fm9]] - hPPARγ + NCOA1 + retinoic acid receptor + retinoic acid + agonist<br />
 +
**[[5ji0]] - hPPARγ + retinoic acid receptor + NCOA1 peptide + antidiabetic drug <br />
 +
**[[3vn2]], [[4hee]], [[4prg]] - hPPARγ + NCOA1 peptide + activator<br />
 +
 
 +
* PPARγ complex with NCAO2
 +
 
 +
**[[1wm0]] – hPPARγ + NCAO2 peptide + agonist<br />
 +
**[[5dwl]], [[5dvc]], [[5dv8]], [[5dv6]], [[5dv3]], [[5dsh]] - hPPARγ + NCAO2 peptide + inhibitor<br />
 +
**[[7sqa]], [[8aqm]], [[8aqn]], [[8b8w]], [[8b8x]], [[8b8y]], [[8b90]], [[8b92]], [[8b93]], [[8b94]], [[8b95]]- hPPARγ + NCOA2 peptide + inverse agonist<br />
 +
**[[8b8z]], [[8b91]] - hPPARγ (mutant) + NCOA2 peptide + inverse agonist<br />
 +
**[[3dzu]], [[3e00]], [[3dzy]] - hPPARγ + DNA + retinoic acid receptor + NCOA2 peptide + retinoic acid<br />
 +
**[[1fm6]] - hPPARγ + antidiabetic drug + retinoic acid receptor + NCOA2 peptide + retinoic acid<br />
 +
 
 +
* PPARγ complex with other proteins
 +
 
 +
**[[1zgy]] – hPPARγ + antidiabetic drug + nuclear receptor peptide<br />
 +
**[[3cs8]], [[3u9q]], [[8bf1]] - hPPARγ + PGC-1A peptide<br />
 +
**[[3cwd]] - hPPARγ + SRC1-2<br />
 +
**[[6oni]], [[6pdz]] - hPPARγ +inverse agonist + NCOR peptide<br />
 +
**[[6ms7]] - hPPARγ + PGC1 LXXLL + modulator<br />
 +
**[[6d94]] - hPPARγ + mediator of RNA polymerase II peptide<br />
 +
**[[6onj]] - hPPARγ + mediator of RNA polymerase II peptide + antidiabetic drug<br />
 +
**[[7rle]] - hPPARγ + CREB-binding protein peptide + agonist<br />
 +
 
 +
*'''PPARδ''';Ligand-binding domain 171-441
 +
 
 +
**[[2gwx]] – hPPARδ<br />
 +
**[[2env]] – hPPARδ zinc finger domain 72-146 - NMR<br />
**[[2baw]], [[2b50]], [[2awh]] – hPPARδ + Vaccenic Acid<br />
**[[2baw]], [[2b50]], [[2awh]] – hPPARδ + Vaccenic Acid<br />
-
**[[3gwx]] – hPPARδ LBD + 5,8,11,14,17-Eicosapentaenoic Acid<br />
+
**[[3gwx]] – hPPARδ + 5,8,11,14,17-Eicosapentaenoic Acid<br />
-
**[[3dy6]] – hPPARδ LBD + anthranilic acid <br />
+
**[[3dy6]] – hPPARδ + anthranilic acid <br />
**[[3et2]], [[1gwx]] – hPPARδ + fatty acid<br />
**[[3et2]], [[1gwx]] – hPPARδ + fatty acid<br />
-
**[[2j14]], [[2xyj]], [[2xyw]], [[2xyx]], [[3oz0]], [[3sp9]], [[5u3q]], [[5u3r]], [[5u3s]], [[5u3t]], [[5u3u]], [[5u3v]], [[5u3w]], [[5u3x]], [[5u3y]], [[5u3z]], [[5u40]], [[5u41]], [[5u42]], [[5u43]], [[5u44]], [[5u45]], [[1gwx]], [[3tkm]], [[1y0s]], [[5u46]], [[5y7x]] - hPPARδ LBD + agonist<br />
+
**[[2j14]], [[2xyj]], [[2xyw]], [[2xyx]], [[3oz0]], [[3sp9]], [[5u3q]], [[5u3r]], [[5u3s]], [[5u3t]], [[5u3u]], [[5u3v]], [[5u3w]], [[5u3x]], [[5u3y]], [[5u3z]], [[5u40]], [[5u41]], [[5u42]], [[5u43]], [[5u44]], [[5u45]], [[1gwx]], [[3tkm]], [[1y0s]], [[5u46]], [[5y7x]], [[7vwf]], [[7vwg]], [[7vwh]], [[7w0g]], [[7wgn]], [[8hul]] - hPPARδ + agonist<br />
-
**[[3peq]] - hPPARδ LBD + partial agonist<br />
+
**[[3peq]] - hPPARδ + partial agonist<br />
-
**[[3d5f]] - hPPARδ LBD + phenoxy derivative<br />
+
**[[3d5f]] - hPPARδ + phenoxy derivative<br />
-
**[[5xmx]], [[6a6p]], [[5zxi]] - hPPARδ LBD + inhibitor<br />
+
**[[5xmx]], [[6a6p]], [[5zxi]], [[7f80]] - hPPARδ + inhibitor<br />
 +
**[[7wgl]] - hPPARd + hyperlipidaemia drug <br />
}}
}}
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

3D Structures of PPAR

Updated on 23-August-2023

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Jaime Prilusky

Retrieved from "http://52.214.119.220/wiki/index.php/Peroxisome_proliferator-activated_receptor_3D_structures"
Personal tools